{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:46:11Z","timestamp":1761896771042},"reference-count":22,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>sCR and non-sCR in acute myeloid leukemia are associated with different prognoses. Three lineage blood cell recoveries have independent impacts on prognosis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017007393","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T01:45:16Z","timestamp":1520646316000},"page":"559-564","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study"],"prefix":"10.1182","volume":"2","author":[{"given":"Andreas K.","family":"\u00d8vlisen","sequence":"first","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Oest","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette D.","family":"Bendtsen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"B\u00e6ch","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preben","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Haematopathology, and"},{"name":"Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line S.","family":"Lynggaard","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aarhus University Hospital, Aarhus, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingolf","family":"M\u00f8lle","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aarhus University Hospital, Aarhus, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Mortensen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Odense University Hospital, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duruta","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Haematology, Odense University Hospital, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Ertner","sequence":"additional","affiliation":[{"name":"Department of Haematology, Herlev Hospital, Herlev, Denmark; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sch\u00f6llkopf","sequence":"additional","affiliation":[{"name":"Department of Haematology, Herlev Hospital, Herlev, Denmark; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Q.","family":"Thomassen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove Juul","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Sofie Granfeldt","family":"\u00d8stg\u00e5rd","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aarhus University Hospital, Aarhus, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"B\u00f8gsted","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Dybk\u00e6r","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans E.","family":"Johnsen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne T.","family":"Severinsen","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aalborg University Hospital, Aalborg, Denmark;"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;"},{"name":"Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"issue":"9550","key":"2019111618291089900_B1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"2019111618291089900_B2","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"2019111618291089900_B3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/CLEP.S48411","article-title":"Data quality in the Danish National Acute Leukemia Registry: a hematological data resource","volume":"5","author":"Ostg\u00e5rd","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2019111618291089900_B4","author":"The Danish Acute Leukemia Group","year":"2014"},{"issue":"24","key":"2019111618291089900_B5","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [published correction appears in J Clin Oncol. 2004;22(3):576","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"2019111618291089900_B6","author":"Hoffman","year":"2013"},{"issue":"10","key":"2019111618291089900_B7","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1200\/JCO.2009.25.1066","article-title":"Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study","volume":"28","author":"Walter","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111618291089900_B8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111618291089900_B9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1200\/JCO.2014.58.3518","article-title":"Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia","volume":"33","author":"Chen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111618291089900_B10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ajh.23834","article-title":"Acute myeloid leukemia: 2014 update on risk-stratification and management","volume":"89","author":"Estey","year":"2014","journal-title":"Am J Hematol"},{"issue":"12","key":"2019111618291089900_B11","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbmt.2011.05.018","article-title":"Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"17","author":"Alatrash","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"18","key":"2019111618291089900_B12","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1200\/JCO.2005.09.133","article-title":"Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia","volume":"23","author":"Feldman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7 suppl","key":"2019111618291089900_B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"4","key":"2019111618291089900_B14","first-page":"441","article-title":"The Danish Civil Registration System. A cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"issue":"7 suppl","key":"2019111618291089900_B15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"1","key":"2019111618291089900_B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CLEP.S9908","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","volume":"2","author":"Erichsen","year":"2010","journal-title":"Clin Epidemiol"},{"key":"2019111618291089900_B17","author":"The Danish Transfusion Database","year":"2015"},{"key":"2019111618291089900_B18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S17901","article-title":"Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark","volume":"3","author":"Grann","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2019111618291089900_B19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2141.2004.05285.x","article-title":"Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies","volume":"128","author":"de Greef","year":"2005","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111618291089900_B20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1507471","article-title":"Assessment of minimal residual disease in standard-risk AML","volume":"374","author":"Ivey","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111618291089900_B21","first-page":"136","article-title":"Haematological cancer: MRD assessment - guiding decisions for patients with AML","volume":"13","author":"Romero","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2019111618291089900_B22","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1056\/NEJMc1603847","article-title":"Assessment of minimal residual disease in standard-risk AML","volume":"375","author":"Othus","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/5\/559\/880335\/advances007393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/5\/559\/880335\/advances007393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T23:29:27Z","timestamp":1573946967000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/5\/559\/15786\/Stringent-or-nonstringent-complete-remission-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017007393","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}